Why transition from alternation to randomisation in clinical trials was made.
作者信息
Chalmers I
出版信息
BMJ. 1999 Nov 20;319(7221):1372. doi: 10.1136/bmj.319.7221.1372.
Abstract
摘要
相似文献
1
Why transition from alternation to randomisation in clinical trials was made.临床试验为何从交替法转变为随机法。
BMJ. 1999 Nov 20;319(7221):1372. doi: 10.1136/bmj.319.7221.1372.
2
Randomisation methods in controlled trials.对照试验中的随机化方法。
BMJ. 1998 Nov 7;317(7168):1301. doi: 10.1136/bmj.317.7168.1301.
3
Tools & techniques methodology and statistics: randomisation in clinical trials.
EuroIntervention. 2013 Jul;9(3):410-1. doi: 10.4244/EIJV9I3A65.
4
Randomisation in clinical trials.
Aust J Physiother. 2005;51(1):58-60. doi: 10.1016/s0004-9514(05)70058-1.
5
Randomised trials--cluster versus individual randomisation. Primary Care Alliance for Clinical Trials (PACT) network.随机试验——整群随机化与个体随机化。初级保健临床试验联盟（PACT）网络。
Aust Fam Physician. 2004 Sep;33(9):759-63.
6
Randomisation.随机化
BMJ. 1991 Jun 22;302(6791):1481-2. doi: 10.1136/bmj.302.6791.1481.
7
Assessing allocation concealment and blinding in randomized controlled trials: why bother?评估随机对照试验中的分配隐藏和盲法：为何要这么做？
ACP J Club. 2000 Mar-Apr;132(2):A11-2.
8
Clinical trials in children with cancer--the problem of early randomisation.
Med Pediatr Oncol. 2000 Aug;35(2):119-21. doi: 10.1002/1096-911x(200008)35:2<119::aid-mpo6>3.0.co;2-2.
9
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.不可预测性悖论：随机对照试验与非随机对照试验实证比较的综述
BMJ. 1998 Oct 31;317(7167):1185-90. doi: 10.1136/bmj.317.7167.1185.
10
The use of unequal randomisation in clinical trials--An update.临床试验中不等随机化的应用——最新进展
Contemp Clin Trials. 2015 Nov;45(Pt A):113-22. doi: 10.1016/j.cct.2015.05.017. Epub 2015 May 28.
引用本文的文献
1
From Model Organisms to Humans, the Opportunity for More Rigor in Methodologic and Statistical Analysis, Design, and Interpretation of Aging and Senescence Research.从模式生物到人类，在衰老和衰老研究的方法学和统计学分析、设计和解释方面有机会更加严谨。
J Gerontol A Biol Sci Med Sci. 2022 Nov 21;77(11):2155-2164. doi: 10.1093/gerona/glab382.
2
Errors in the implementation, analysis, and reporting of randomization within obesity and nutrition research: a guide to their avoidance.肥胖与营养研究中随机化实施、分析和报告中的错误：避免方法指南。
Int J Obes (Lond). 2021 Nov;45(11):2335-2346. doi: 10.1038/s41366-021-00909-z. Epub 2021 Jul 29.
3
Interventions for ulceration and other skin changes caused by nerve damage in leprosy.麻风病神经损伤所致溃疡及其他皮肤病变的干预措施。
Cochrane Database Syst Rev. 2019 Jul 31;7(7):CD012235. doi: 10.1002/14651858.CD012235.pub2.
4
A methodological framework for drug development in rare diseases.罕见病药物研发的方法框架。
Orphanet J Rare Dis. 2014 Nov 18;9:164. doi: 10.1186/s13023-014-0164-y.
5
UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.英国医学研究理事会与多中心临床试验：从一份严厉的报告到国际认可。
J R Soc Med. 2013 Dec;106(12):498-509. doi: 10.1177/0141076813510452.
6
Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers.为何1948年医学研究委员会的链霉素试验采用基于随机数字的治疗分配方法。
J R Soc Med. 2011 Sep;104(9):383-6. doi: 10.1258/jrsm.2011.11k023.
7
The history of confounding.混杂因素的历史。
Soz Praventivmed. 2002;47(4):216-24. doi: 10.1007/BF01326402.
本文引用的文献
1
THE SERUM TREATMENT OF LOBAR PNEUMONIA: A REPORT OF THE THERAPEUTIC TRIALS COMMITTEE OF THE MEDICAL RESEARCH COUNCIL.大叶性肺炎的血清治疗：医学研究理事会治疗试验委员会报告
Br Med J. 1934 Feb 10;1(3814):241-5.
2
A change in scientific approach: from alternation to randomised allocation in clinical trials in the 1940s.科学方法的转变：20世纪40年代临床试验中从交替分配到随机分配。
BMJ. 1999 Aug 28;319(7209):572-3. doi: 10.1136/bmj.319.7209.572.
3
Statistics notes. Treatment allocation in controlled trials: why randomise?统计学笔记。对照试验中的治疗分配：为何要随机化？
BMJ. 1999 May 1;318(7192):1209. doi: 10.1136/bmj.318.7192.1209.
Zotero 插件